Explore "continuingmedicaleducation" with insightful episodes like "Patient Identification for Residual Risk Management: Who’s At Risk? with Drs. Pamela Morris and Martha Gulati", "Strategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What’s the Risk? with Drs. Pamela Morris and Martha Gulati", "Efficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. Allegretti", "Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn" and "Mechanisms of Action of New Classes of Agents for Moderate to Severe Crohn’s Disease with Drs. William J. Sandborn and Bruce E. Sands" from podcasts like ""MedEdTalks - Cardiology", "MedEdTalks - Cardiology", "MedEdTalks - Gastroenterology", "MedEdTalks - Gastroenterology" and "MedEdTalks - Gastroenterology"" and more!
In this podcast, expert clinicians will discuss secondary prevention and how to identify patients who may benefit from additional treatment to reduce CV risk.
In this podcast, expert clinicians discuss primary prevention as well as strategies for ASCVD risk assessment.
In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-IL-23 and JAK inhibitors, that are in late-stage development for treating moderate to severe CD.
In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-integrin and S1P-1 receptor modulators, that are in late-stage development for treating moderate to severe CD.
In this podcast, expert clinicians will discuss emerging therapies with unique mechanisms of action that can improve the treatment of moderate to severe Crohn’s disease.
In this podcast, expert clinicians will discuss a challenging case in the treatment of neurotrophic keratitis.
In this podcast, expert clinicians will discuss a challenging case in the staging and diagnosis of neurotrophic keratitis.
In this podcast, expert clinicians will discuss different treatment options for neurotrophic keratitis.
In this podcast, expert clinicians will discuss pathophysiology, diagnosis, and staging of neurotrophic keratitis.
In this podcast, expert clinicians will discuss the future treatment of Alzheimer’s disease, examining mechanisms of action and clinical trial data for emerging agents.
In this podcast, expert clinicians will discuss the current available therapies for Alzheimer’s disease and the strengths and weaknesses of these therapies.
In this podcast, expert clinicians will discuss the pathological hallmarks of Alzheimer’s disease and how to differentiate Alzheimer’s from other dementias.
In this podcast, expert clinicians will discuss the importance of early diagnosis in Alzheimer’s disease and assessment tools for making an early diagnosis.
In this podcast, expert clinicians will discuss the potential use of sGC modulators in the management of patients with heart failure with reduced ejection fraction (HFrEF).
In this podcast, expert clinicians will discuss the safety and efficacy of sGC modulators that was seen in various clinical trials.
In this podcast, expert clinicians will discuss the mechanism of action of sGC modulators and the rationale for its use in patients with heart failure.
In this podcast, expert clinicians will discuss the burden of heart failure in the United States and the potential of new therapies for treating heart failure.
Antiretroviral therapy (ART) has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already-diverse field of HIV treatment. In this CE activity, participants will listen to expert faculty in a series of six podcasts. The faculty of this program will explore various aspects of HIV management, including recent guideline revisions, use of 2-drug regimens, individualizing ART regimens in patients with HIV and comorbidities, as well as the management of patients with HIV who are highly treatment-experienced. In addition, the potential use of long-acting injectable ART formulations in patients with HIV who struggle with stigma and/or adherence as well as advances in pre-exposure prophylaxis are examined.
In this podcast, expert clinicians will discuss the importance of empathy in caring for patients with rheumatic diseases. Key aspects of empathy such as listening, eye contact, and reading body language are included. Listen in as Drs. Len and Cassie Calabrese discuss the critical aspects of empathy for rheumatology providers.
For CME Credit, complete activity here: https://tinyurl.com/Rheumatology3
In this podcast series, expert clinicians will discuss optimal vaccine practices for rheumatology providers. Herpes zoster, influenza, and pneumococcal vaccine administration will be discussed. Listen in as Dr. Len and Cassandra Calabrese discuss important details on vaccination for rheumatology providers.
For CME Credit, complete activity here: https://tinyurl.com/Rheumatology2
Stay up to date
For any inquiries, please email us at hello@podcastworld.io